Yesterday (12/17/08) the U.S. FDA sent a "No Objection Letter" to Merisant's Whole Earth Sweetener company and to Cargill, Inc., responding to their long awaited request to market a highly purified form of Stevia known as Reb A (rebaudioside A). Translated this letter means that FDA has no objection to the conclusion that both companies reached independently using the GRAS self-affirmation process: that Reb A is generally recognized as safe among qualified experts for use in beverages, foods and tabletop sweeteners.
With all the conversation about the need for health care reform, there are no better places to focus our efforts and energy than on the prevention and better management of diabetes by supporting people's and society's work on living healthier lifestyles. Both obesity, often the predecessor to pre- and type 2 diabetes, and type 2 diabetes eat up a massive piece of the healthcare dollar pie. A focus on prevention of obesity and type 2 diabetes could offer us big benefits for our bucks!